Wealth Enhancement Advisory Services’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Other funds holding FULC
Wealth Enhancement Advisory Services's FULC Position: Q3 2026 in Review
Wealth Enhancement Advisory Services sold out of Fulcrum Therapeutics (FULC) in Q3 2026, closing a stake of 10,254 shares — an estimated $35.9K sold.
Wealth Enhancement Advisory Services first reported a position in FULC in Q2 2026 and held it in 1 quarter. The position peaked at $35.9K in Q2 2026. 151 funds tracked by Wall St. Rank hold FULC as of Q3 2026.
- Wealth Enhancement Advisory Services reported no remaining Fulcrum Therapeutics position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Advisory Services sold 10,254 Fulcrum Therapeutics shares in Q3 2026, an estimated $35.9K.
- Wealth Enhancement Advisory Services first reported a position in Fulcrum Therapeutics in Q2 2026 and held it in 1 quarter.
- Wealth Enhancement Advisory Services's Fulcrum Therapeutics position peaked at $35.9K in Q2 2026.
- 151 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.